COVID-19: 220m vaccine doses to be tested in Africa…….WHO

Spread the love

Efforts to produce a vaccine to curb the spread of the lethal virus Covid19 is yielding results as the World Health Organisation (WHO) declared that 220 million COVID-19 vaccine doses will be tested on the African population.

Confirming the latest development, WHO’s Africa program manager Richard Mihigo said the distribution will be based on nation inhabitant numbers and front-line health workers and the most vulnerable being given first-batch priority.

Dr. Richard Mihigo,  who is also WHO’s Africa immunization and vaccines coordinator, explained the process involved. “This will not necessarily cover all the needs of the continent but at least will cover 20 percent of the African population, initially prioritizing those that are on the frontline, healthcare workers, then expanding to cover vulnerable groups such as the elderly or those with a pre-existing condition.”

COVAX is the global vaccine initiative that consists of nine vaccine candidates being tested around the world two of which are already being tested in Africa, according to the head of the Coalition for Epidemic Preparedness Innovations (CEPI), Richard Hatchett.

This initiative intends to contribute to the purchase and equitable distribution of 2 billion doses of approved vaccines by the year-end of 2021.

Please wait...

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know.